Aldeyra The (ALDX) vs Champions Oncology, Inc. (CSBR)
A side-by-side comparison of Aldeyra The and Champions Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
CSBR
Champions Oncology, Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALDX vs CSBR
growth of $100 · dividends reinvested · last 10yALDX -87.7% (-18.9%/yr)CSBR +208.7% (+11.9%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
ALDX CSBR
ALDX vs CSBR: by the numbers
- •CSBR is the larger company ($70M vs $55M market cap).
- •Both run net losses; ALDX's is the smaller (0.00% vs -1.87% net margin).
Metrics side by side
Valuation
| Metric | ALDX | CSBR |
|---|---|---|
| Forward P/E | N/A | 50.10 |
| P/S ratio | N/A | 1.15 |
| P/B ratio | 1.46 | 17.88 |
| EV / EBITDA | N/A | 261.92 |
Profitability
| Metric | ALDX | CSBR |
|---|---|---|
| Gross margin | 0.00% | 49.30% |
| Operating margin | 0.00% | -1.72% |
| Net margin | 0.00% | -1.87% |
| ROE | -60.85% | -29.15% |
| ROIC | -63.52% | -6.75% |
Growth (annualized)
| Metric | ALDX | CSBR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.25% |
| Total return CAGR (5Y) | -36.54% | -13.07% |
Frequently asked
- How have ALDX and CSBR total returns compared?
- Over the past 10 years, ALDX delivered -18.91% and CSBR delivered 12.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.